These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 23671038)
1. Mapping neurotransmitter networks with PET: an example on serotonin and opioid systems. Tuominen L; Nummenmaa L; Keltikangas-Järvinen L; Raitakari O; Hietala J Hum Brain Mapp; 2014 May; 35(5):1875-84. PubMed ID: 23671038 [TBL] [Abstract][Full Text] [Related]
2. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Gorelick DA; Kim YK; Bencherif B; Boyd SJ; Nelson R; Copersino M; Endres CJ; Dannals RF; Frost JJ Biol Psychiatry; 2005 Jun; 57(12):1573-82. PubMed ID: 15953495 [TBL] [Abstract][Full Text] [Related]
3. Adult Attachment System Links With Brain Mu Opioid Receptor Availability In Vivo. Turtonen O; Saarinen A; Nummenmaa L; Tuominen L; Tikka M; Armio RL; Hautamäki A; Laurikainen H; Raitakari O; Keltikangas-Järvinen L; Hietala J Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Mar; 6(3):360-369. PubMed ID: 33431346 [TBL] [Abstract][Full Text] [Related]
4. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Zubieta JK; Ketter TA; Bueller JA; Xu Y; Kilbourn MR; Young EA; Koeppe RA Arch Gen Psychiatry; 2003 Nov; 60(11):1145-53. PubMed ID: 14609890 [TBL] [Abstract][Full Text] [Related]
5. Regional brain [(11)C]carfentanil binding following tobacco smoking. Domino EF; Hirasawa-Fujita M; Ni L; Guthrie SK; Zubieta JK Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jun; 59():100-104. PubMed ID: 25598501 [TBL] [Abstract][Full Text] [Related]
6. Gender and age influences on human brain mu-opioid receptor binding measured by PET. Zubieta JK; Dannals RF; Frost JJ Am J Psychiatry; 1999 Jun; 156(6):842-8. PubMed ID: 10360121 [TBL] [Abstract][Full Text] [Related]
7. Temperament trait Harm Avoidance associates with μ-opioid receptor availability in frontal cortex: a PET study using [(11)C]carfentanil. Tuominen L; Salo J; Hirvonen J; Någren K; Laine P; Melartin T; Isometsä E; Viikari J; Raitakari O; Keltikangas-Järvinen L; Hietala J Neuroimage; 2012 Jul; 61(3):670-6. PubMed ID: 22484309 [TBL] [Abstract][Full Text] [Related]
8. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Kennedy SE; Koeppe RA; Young EA; Zubieta JK Arch Gen Psychiatry; 2006 Nov; 63(11):1199-208. PubMed ID: 17088500 [TBL] [Abstract][Full Text] [Related]
9. Dopamine synthesis capacity correlates with µ-opioid receptor availability in the human basal ganglia: A triple-tracer PET study. Majuri J; Joutsa J; Arponen E; Forsback S; Kaasinen V Neuroimage; 2018 Dec; 183():1-6. PubMed ID: 30077742 [TBL] [Abstract][Full Text] [Related]
10. Altered central micro-opioid receptor binding after psychological trauma. Liberzon I; Taylor SF; Phan KL; Britton JC; Fig LM; Bueller JA; Koeppe RA; Zubieta JK Biol Psychiatry; 2007 May; 61(9):1030-8. PubMed ID: 16945349 [TBL] [Abstract][Full Text] [Related]
11. Dissociable Roles of Cerebral μ-Opioid and Type 2 Dopamine Receptors in Vicarious Pain: A Combined PET-fMRI Study. Karjalainen T; Karlsson HK; Lahnakoski JM; Glerean E; Nuutila P; Jääskeläinen IP; Hari R; Sams M; Nummenmaa L Cereb Cortex; 2017 Aug; 27(8):4257-4266. PubMed ID: 28541428 [TBL] [Abstract][Full Text] [Related]
12. Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans. Prossin AR; Zalcman SS; Heitzeg MM; Koch AE; Campbell PL; Phan KL; Stohler CS; Zubieta JK Neuropsychopharmacology; 2015 Feb; 40(3):554-65. PubMed ID: 25139063 [TBL] [Abstract][Full Text] [Related]
13. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans. Scott DJ; Domino EF; Heitzeg MM; Koeppe RA; Ni L; Guthrie S; Zubieta JK Neuropsychopharmacology; 2007 Feb; 32(2):450-7. PubMed ID: 17091130 [TBL] [Abstract][Full Text] [Related]
14. Low- and high-frequency transcutaneous electrical acupoint stimulation induces different effects on cerebral μ-opioid receptor availability in rhesus monkeys. Xiang XH; Chen YM; Zhang JM; Tian JH; Han JS; Cui CL J Neurosci Res; 2014 May; 92(5):555-63. PubMed ID: 24482187 [TBL] [Abstract][Full Text] [Related]
15. Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study. Schrepf A; Harper DE; Harte SE; Wang H; Ichesco E; Hampson JP; Zubieta JK; Clauw DJ; Harris RE Pain; 2016 Oct; 157(10):2217-2225. PubMed ID: 27420606 [TBL] [Abstract][Full Text] [Related]
16. Measurement of central mu-opioid receptor binding in vivo with PET and [11C]carfentanil: a test-retest study in healthy subjects. Hirvonen J; Aalto S; Hagelberg N; Maksimow A; Ingman K; Oikonen V; Virkkala J; Någren K; Scheinin H Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):275-86. PubMed ID: 18779961 [TBL] [Abstract][Full Text] [Related]
17. Application of MRI-based partial-volume correction to the analysis of PET images of mu-opioid receptors using statistical parametric mapping. Bencherif B; Stumpf MJ; Links JM; Frost JJ J Nucl Med; 2004 Mar; 45(3):402-8. PubMed ID: 15001679 [TBL] [Abstract][Full Text] [Related]
18. Simple and rapid quantification of serotonin transporter binding using [ Gryglewski G; Rischka L; Philippe C; Hahn A; James GM; Klebermass E; Hienert M; Silberbauer L; Vanicek T; Kautzky A; Berroterán-Infante N; Nics L; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R Neuroimage; 2017 Apr; 149():23-32. PubMed ID: 28119137 [TBL] [Abstract][Full Text] [Related]